[HTML][HTML] Circulating angiogenic factors and the risk of preeclampsia
…, KF Yu, EF Schisterman, R Thadhani… - New England journal …, 2004 - Mass Medical Soc
Background The cause of preeclampsia remains unclear. Limited data suggest that excess
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor (…
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor (…
[HTML][HTML] Hypovitaminosis D in medical inpatients
…, DM Lloyd-Jones, RI Thadhani… - … England Journal of …, 1998 - Mass Medical Soc
Background Vitamin D deficiency is a major risk factor for bone loss and fracture. Although
hypovitaminosis D has been detected frequently in elderly and housebound people, the …
hypovitaminosis D has been detected frequently in elderly and housebound people, the …
[HTML][HTML] Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury
WK Han, V Bailly, R Abichandani, R Thadhani… - Kidney international, 2002 - Elsevier
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury.
Background Traditional blood and urine markers for the diagnosis of various renal diseases …
Background Traditional blood and urine markers for the diagnosis of various renal diseases …
Calciphylaxis: risk factors, diagnosis, and treatment
…, MM Kamdar, DJR Steele, RI Thadhani - American Journal of …, 2015 - Elsevier
Calciphylaxis is a rare but devastating condition that has continued to challenge the medical
community since its early descriptions in the scientific literature many decades ago. It is …
community since its early descriptions in the scientific literature many decades ago. It is …
[HTML][HTML] Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
…, FH Epstein, R Romero, R Thadhani… - … England Journal of …, 2006 - Mass Medical Soc
Background Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic
protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be …
protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be …
[HTML][HTML] Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
…, A Shah, K Smith, H Lee, R Thadhani… - … England Journal of …, 2008 - Mass Medical Soc
Background Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of
urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D, thus …
urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D, thus …
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition …
…, D Pan, A Zadshir, N Tareen, R Thadhani… - Archives of internal …, 2007 - jamanetwork.com
Background Results of several epidemiologic and clinical studies have suggested that there
is an excess risk of hypertension and diabetes mellitus in persons with suboptimal intake of …
is an excess risk of hypertension and diabetes mellitus in persons with suboptimal intake of …
[HTML][HTML] Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
…, N Ofsthun, JM Lazarus, R Thadhani - … England Journal of …, 2003 - Mass Medical Soc
Background Elevated calcium and phosphorus levels after therapy with injectable vitamin D
for secondary hyperparathyroidism may accelerate vascular disease and hasten death in …
for secondary hyperparathyroidism may accelerate vascular disease and hasten death in …
[HTML][HTML] Vitamin D–binding protein and vitamin D status of black Americans and white Americans
…, SA Karumanchi, NR Powe, R Thadhani - … England Journal of …, 2013 - Mass Medical Soc
Background Low levels of total 25-hydroxyvitamin D are common among black Americans.
Vitamin D–binding protein has not been considered in the assessment of vitamin D deficiency…
Vitamin D–binding protein has not been considered in the assessment of vitamin D deficiency…
Activated injectable vitamin D and hemodialysis survival: a historical cohort study
…, MA Hernán, CA Camargo Jr, R Thadhani - Journal of the …, 2005 - journals.lww.com
Patients with ESRD commonly experience secondary hyperparathyroidism, a condition primarily
managed with activated injectable vitamin D. The biologic effects of vitamin D, however, …
managed with activated injectable vitamin D. The biologic effects of vitamin D, however, …